KCM
INO icon

Knoll Capital Management’s Inovio Pharmaceuticals INO Stock Holding History

Knoll Capital Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-6,841
Closed -$754K – 18
2014
Q4 		$754K Sell
6,841
-1,666
-20% -$204K 0.3% 10
2014
Q3 		$1.01M Hold
8,507
– – 0.39% 8
2014
Q2 		$1.11M Hold
8,507
– – 0.49% 8
2014
Q1 		$1.36M Hold
8,507
– – 0.7% 8
2013
Q4 		$1.17M Buy
+8,507
New +$851K 0.59% 8

Other funds holding INO

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Knoll Capital Management's INO Position: Q1 2015 in Review

Knoll Capital Management sold out of Inovio Pharmaceuticals (INO) in Q1 2015, closing a stake of 6,841 shares — an estimated $754K sold.

Knoll Capital Management first reported a position in INO in Q4 2013 and held it in 5 quarters. The position peaked at $1.36M in Q1 2014. 98 funds tracked by Wall St. Rank hold INO as of Q1 2015.

  • Knoll Capital Management reported no remaining Inovio Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Knoll Capital Management sold 6,841 Inovio Pharmaceuticals shares in Q1 2015, an estimated $754K.
  • Knoll Capital Management first reported a position in Inovio Pharmaceuticals in Q4 2013 and held it in 5 quarters.
  • Knoll Capital Management's Inovio Pharmaceuticals position peaked at $1.36M in Q1 2014.
  • 98 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2015.

Based on Knoll Capital Management's 13F filing for Q1 2015, filed 15 May 2015.